In addition to TLR2 and TLR4 in GBS, TLR9 expression was also increased in PBMCs, which promoted the secretion of IFN-γ and positively correlated with the degree of disability of GBS (122). The gene discussed is TLR2; the disease is Guillain-Barre syndrome.